Profil
Daisuke Morishita is associated with Chordia Therapeutics, Inc. as the Chief Scientific Officer since 2017.
He is the founder of Chordia Therapeutics, Inc. which was founded in 2017.
Postes actifs de Daisuke Morishita
| Sociétés | Poste | Début |
|---|---|---|
| CHORDIA THERAPEUTICS INC. | Fondateur | 12/10/2017 |
Expériences
Fonctions occupées
Relations
6
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Chordia Therapeutics, Inc.
 Chordia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chordia Therapeutics, Inc. engages in the research and development of novel therapies for cancers. It handles research and development of low-molecular-weight drugs with unprecedented new mechanisms of action in the oncology area. The company was founded by Hiroshi Miyake and Daisuke Morishita on October 12, 2017 and is headquartered in Fujisawa, Japan. | Health Technology |